The selective triggering of CD40 on keratinocytes in vivo enhances cell‐mediated immunity

CD40 is expressed on a wide array of hematopoietic and non‐hematopoietic cells, including keratinocytes. The pivotal in vivo function of CD40 on hematopoietic cells in the regulation of both humoral and cell‐mediated immunity is well established. However, whether CD40 expression on non‐hematopoietic cells influences immunity has until now not been addressed. Therefore, we transgenically expressed human CD40 (hCD40) under the control of the keratin 14 promoter to drive expression of hCD40 in basal keratinocytes of mice. When we selectively engaged hCD40 in vivo on the keratinocytes of these mice, the keratinocytes secreted TNF‐α, resulting in dendritic cell migration to draining lymph nodes and enhanced in vitro T cell priming to an epicutaneously applied chemical sensitizer. Exclusive CD40 engagement on keratinocytes during a contact hypersensitivity response displayed exacerbated and prolonged cutaneous immune reactions relative to control mice. Thus, CD40 engagement on non‐hematopoietic cells, such as keratinocytes, can amplify cutaneous and regional T cell responses in vivo.

[1]  C. Bucana,et al.  Cd40–Cd40 Ligand Interactions in Vivo Regulate Migration of Antigen-Bearing Dendritic Cells from the Skin to Draining Lymph Nodes , 2000, The Journal of experimental medicine.

[2]  D. Schmitt,et al.  CD40 ligation alters the cell cycle of differentiating keratinocytes. , 2000, The Journal of investigative dermatology.

[3]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[4]  S. Miller,et al.  Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis. , 1999, The Journal of clinical investigation.

[5]  R. Noelle,et al.  CD40 and its crucial role as a member of the TNFR family. , 1998, Seminars in immunology.

[6]  D. Schmitt,et al.  Effects of CD40 ligation on human keratinocyte accessory function , 1998, Archives of Dermatological Research.

[7]  R. Barth,et al.  Characterization of the altered cutaneous reactivity of transgenic mice whose keratinocytes overexpress B7-1. , 1998, Clinical immunology and immunopathology.

[8]  T. Mak,et al.  Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. , 1997, Journal of immunology.

[9]  J. Banchereau,et al.  CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. , 1997, Journal of immunology.

[10]  Alejandro Aruffo,et al.  CD40 is functionally expressed on human keratinocytes , 1996, European journal of immunology.

[11]  L. Glimcher,et al.  Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex , 1996, Nature.

[12]  A. Gaspari,et al.  Human epidermal keratinocytes are induced to secrete interleukin‐6 and co‐stimulate T lymphocyte proliferation by a CD40‐dependent mechanism , 1996, European journal of immunology.

[13]  T. Kupper,et al.  Keratinocyte expression of B7-1 in transgenic mice amplifies the primary immune response to cutaneous antigens. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Kupper,et al.  Epidermal expression of intercellular adhesion molecule 1 is not a primary inducer of cutaneous inflammation in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Barth,et al.  Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. , 1994, The Journal of clinical investigation.

[16]  B. Ehlin‐Henriksson,et al.  The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. , 1989, Journal of immunology.

[17]  E. Fuchs,et al.  Localization of keratin mRNA in human tracheobronchial epithelium and bronchogenic carcinomas by in situ hybridization. , 1988, The American journal of pathology.

[18]  P. Libby,et al.  The CD40/CD154 receptor/ligand dyadRID="†"ID="†" Review , 2001, Cellular and Molecular Life Sciences CMLS.

[19]  J Bajorath,et al.  Immune regulation by CD40 and its ligand GP39. , 1996, Annual review of immunology.